Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hospira One 2 One To Supply Solithromycin | Contract Pharma

What are you searching for?

Sign in
Breaking News

Hospira One 2 One To Supply Solithromycin

Cempra to develop IV version of antibiotic

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cempra Pharmaceuticals has entered into an agreement with Hospira One 2 One to develop an intravenous form of its lead antibiotic candidate, solithromycin. Hospira One 2 One will supply the IV version of the antibiotic for clinical development and potential commercial supply. Financial terms were not disclosed. This story was first reported by Triangle Business Journal Online.
 
If the drug reaches approval, Cempra will purchase at least 80% of its commercial product from Hospira, according to a recent 8-K filing by Cempra. The IV version is currently in Phase II trials, while an oral version began a Phase III trial against community-acquired bacterial pneumonia in December 2012. The IV version will also be tested against that indication.

“The One 2 One™ team is excited to assist Cempra Pharmaceuticals in the development and manufacture of their novel antibiotic product, Solithromycin. We appreciate the trust that Cempra Pharmaceuticals places with Hospira’s anti-infective and lyophilization expertise. I look forward to the day this promising drug can obtain approval and reach patients,” said Karen Blair, vice president, general manager, One 2 One™ Global Pharmaceutical Services.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics